dihydrotestosterone has been researched along with Epithelial Ovarian Cancer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gabler, F; Kohan-Ivani, K; Romero, C; Selman, A; Vega, M | 1 |
| Cross, P; Edmondson, RJ; Elattar, A; Freer, RM; Mukhopadhyay, A; Plummer, ER; Robson, CN; Shaheen, F; Warburton, KG | 1 |
2 other study(ies) available for dihydrotestosterone and Epithelial Ovarian Cancer
| Article | Year |
|---|---|
Role of dihydrotestosterone (DHT) on TGF-β1 signaling pathway in epithelial ovarian cancer cells.
Topics: Androgens; Apoptosis; Blotting, Western; Carcinoma, Ovarian Epithelial; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p21; Dihydrotestosterone; Female; Gene Expression Regulation, Neoplastic; Humans; Immunoenzyme Techniques; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Ovary; Protein Serine-Threonine Kinases; Real-Time Polymerase Chain Reaction; Receptor, Transforming Growth Factor-beta Type I; Receptor, Transforming Growth Factor-beta Type II; Receptors, Androgen; Receptors, Transforming Growth Factor beta; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Smad2 Protein; Transforming Growth Factor beta1; Tumor Cells, Cultured | 2016 |
Androgen receptor expression is a biological marker for androgen sensitivity in high grade serous epithelial ovarian cancer.
Topics: Androgens; Ascitic Fluid; Biomarkers, Tumor; Carcinoma, Ovarian Epithelial; Cystadenocarcinoma, Serous; Dihydrotestosterone; Exons; Female; Humans; Immunohistochemistry; Neoplasm Grading; Neoplasms, Glandular and Epithelial; Neoplasms, Hormone-Dependent; Ovarian Neoplasms; Receptors, Androgen; RNA, Messenger; S Phase; Stimulation, Chemical; Trinucleotide Repeats; Tumor Cells, Cultured | 2012 |